Učitavanje...
Nanocomposite Microparticles (nCmP) for the Delivery of Tacrolimus in the Treatment of Pulmonary Arterial Hypertension
Tacrolimus (TAC) has exhibited promising therapeutic potential in the treatment of pulmonary arterial hypertension (PAH); however, its application is prevented by its poor solubility, instability, poor bioavailability, and negative systemic side effects. To overcome the obstacles of using TAC for th...
Spremljeno u:
| Izdano u: | Int J Pharm |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5030191/ https://ncbi.nlm.nih.gov/pubmed/27568494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2016.08.047 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|